Is Development of a Vaccine against Cryptococcus neoformans Feasible?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is Development of a Vaccine against Cryptococcus neoformans Feasible?
Authors
Keywords
Cryptococcus neoformans, Macrophages, Cryptococcosis, Immune response, Vaccines, Cell-mediated immunity, Cytokines, T cells
Journal
PLoS Pathogens
Volume 11, Issue 6, Pages e1004843
Publisher
Public Library of Science (PLoS)
Online
2015-06-19
DOI
10.1371/journal.ppat.1004843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deoxynucleic Acids from Cryptococcus neoformans Activate Myeloid Dendritic Cells via a TLR9-Dependent Pathway
- (2014) K. Nakamura et al. JOURNAL OF IMMUNOLOGY
- Bronchial Epithelial Cells Induce Alternatively Activated Dendritic Cells Dependent on Glucocorticoid Receptor Signaling
- (2014) M. Weitnauer et al. JOURNAL OF IMMUNOLOGY
- STAT1 Signaling Is Essential for Protection againstCryptococcus neoformansInfection in Mice
- (2014) Chrissy M. Leopold Wager et al. JOURNAL OF IMMUNOLOGY
- Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections
- (2014) C M Leopold Wager et al. Mucosal Immunology
- Cryptococcus neoformans and Cryptococcus gattii, the Etiologic Agents of Cryptococcosis
- (2014) K. J. Kwon-Chung et al. Cold Spring Harbor Perspectives in Medicine
- Cryptococcusantigens and immune responses: implications for a vaccine
- (2013) Ashok K Chaturvedi et al. Expert Review of Vaccines
- Macrophage M1/M2 Polarization Dynamically Adapts to Changes in Cytokine Microenvironments in Cryptococcus neoformans Infection
- (2013) M. J. Davis et al. mBio
- Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases
- (2012) Arturo Casadevall et al. Cell Host & Microbe
- Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes
- (2012) Jessica Quintin et al. Cell Host & Microbe
- Protective Immunity against Pulmonary Cryptococcosis Is Associated with STAT1-Mediated Classical Macrophage Activation
- (2012) S. E. Hardison et al. JOURNAL OF IMMUNOLOGY
- Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
- (2012) J. Kleinnijenhuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternatively activated dendritic cells regulate CD4+ T-cell polarization in vitro and in vivo
- (2012) P. C. Cook et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic Cells: Arbiters of Immunity and Immunological Tolerance
- (2012) K. L. Lewis et al. Cold Spring Harbor Perspectives in Biology
- Trained Immunity: A Memory for Innate Host Defense
- (2011) Mihai G. Netea et al. Cell Host & Microbe
- Protective Immunity against Experimental Pulmonary Cryptococcosis in T Cell-Depleted Mice
- (2011) Karen L. Wozniak et al. Clinical and Vaccine Immunology
- Pulmonary Infection with an Interferon-γ-Producing Cryptococcus neoformans Strain Results in Classical Macrophage Activation and Protection
- (2010) Sarah E. Hardison et al. AMERICAN JOURNAL OF PATHOLOGY
- Mechanisms of cryptococcal virulence and persistence
- (2010) Michal A Olszewski et al. Future Microbiology
- Interleukin-17 Is Not Required for Classical Macrophage Activation in a Pulmonary Mouse Model of Cryptococcus neoformans Infection
- (2010) S. E. Hardison et al. INFECTION AND IMMUNITY
- Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
- (2009) Benjamin J Park et al. AIDS
- Cryptococcus neoformans Enters the Endolysosomal Pathway of Dendritic Cells and Is Killed by Lysosomal Components
- (2008) K. L. Wozniak et al. INFECTION AND IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More